WAM
AVNS icon

Wakefield Asset Management’s Avanos Medical AVNS Stock Holding History

Wakefield Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,356
Closed -$666K – 152
2022
Q2 		$666K Buy
24,356
+90
+0.4% +$2.59K 0.29% 99
2022
Q1 		$813K Buy
+24,266
New +$781K 0.29% 107
2021
Q2 		– Sell
-14,135
Closed -$618K – 156
2021
Q1 		$618K Sell
14,135
-518
-4% -$24.3K 0.25% 123
2020
Q4 		$672K Buy
+14,653
New +$610K 0.28% 106

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wakefield Asset Management's AVNS Position: Q3 2022 in Review

Wakefield Asset Management sold out of Avanos Medical (AVNS) in Q3 2022, closing a stake of 24,356 shares — an estimated $666K sold.

Wakefield Asset Management first reported a position in AVNS in Q4 2020 and held it in 4 quarters. The position peaked at $813K in Q1 2022. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2022.

  • Wakefield Asset Management reported no remaining Avanos Medical position as of Q3 2022 after selling out during the quarter.
  • Wakefield Asset Management sold 24,356 Avanos Medical shares in Q3 2022, an estimated $666K.
  • Wakefield Asset Management first reported a position in Avanos Medical in Q4 2020 and held it in 4 quarters.
  • Wakefield Asset Management's Avanos Medical position peaked at $813K in Q1 2022.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2022.

Based on Wakefield Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.